February 1, 1989The Thoracic and Cardiovascular Surgeon

Heart Transplantation - The Treatment of Choice for Patients With End-Stage Ischaemic Heart Disease

View Full Paper

Ask AI

Bookmark

Why the study?

Does heart transplantation improve survival and functional status in patients with end-stage ischaemic heart disease?

Structured PICO

Does heart transplantation improve survival and functional status in patients with end-stage ischaemic heart disease?

Population

128 patients who underwent 147 heart transplants between 1967 and 1988, primarily for dilated cardiomyopathy or end-stage ischaemic heart disease, including a detailed subgroup of 17 patients (mean age 46.6 years) with NYHA IV coronary artery disease, severe 3-vessel disease, and mean LVEF 15.3%.

Intervention

Heart transplantation (orthotopic, heterotopic, or heart-and-lung replacement)

Outcome

Survival (actuarial 90-day and 1-year survival rates)hard clinical

Heart transplantation provides excellent short- to medium-term survival and functional recovery for patients with end-stage ischaemic heart disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support transplantation in end-stage ischaemic heart disease; hypothesis-generating case series requiring prospective validation.

Cite This Study

Hildebrandt et al. (1989) studied this question.

synapsesocial.com/papers/6a74c9ad696556ffb2f54254 https://doi.org/10.1055/s-2007-1013902

Topics

Heart transplantation

View Full Paper

Ask AI

Bookmark

Heart Transplantation - The Treatment of Choice for Patients With End-Stage Ischaemic Heart Disease

Structured PICO

Discussion

Implication

Cite This Study

Topics

Heart Transplantation - The Treatment of Choice for Patients With End-Stage Ischaemic Heart Disease

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider